Menu
Annual · values2025202420232022202120202019
Operating Cash Flow-15.97 M USD-37.17 M USD-34.58 M USD-30.65 M USD-17.19 M USD-4.49 M USD-7.67 M USD
Depreciation & Amortization10.62 M USD8.42 M USD5.35 M USD2.13 M USD685000 USD1.21 M USD793000 USD
Stock-Based Compensation33.82 M USD30.60 M USD17.35 M USD8.11 M USD3.41 M USD919000 USD815000 USD
Capital Expenditures13.52 M USD11.59 M USD11.46 M USD14.84 M USD2.71 M USD1.07 M USD1.21 M USD
Cash Flow from Investing13.25 M USD35.38 M USD-81.30 M USD-76.52 M USD-2.71 M USD-1.07 M USD-1.21 M USD
Cash Flow from Financing2.08 M USD160000 USD109.38 M USD20.81 M USD107.65 M USD11.50 M USD19.74 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-29.49 M USD-48.76 M USD-46.03 M USD-45.49 M USD-19.90 M USD-5.56 M USD-8.88 M USD

Treace Medical Concepts Inc. specializes in medical device development, focusing primarily on orthopedic solutions. Its flagship product is the Lapiplasty 3D Bunion Correction System, designed to address common deformities associated with bunions. This innovative system allows for precise correction in three dimensions, providing a unique, cutting-edge solution in the podiatric surgery field. Targeting hospitals, surgeons, and healthcare providers, Treace Medical Concepts plays a significant role in the medical sector by offering improved patient outcomes and recovery experiences. Headquartered in Ponte Vedra, Florida, the company supports its distribution through a strong network of sales representatives and medical partnerships in the United States. By integrating research and technology into its product design, Treace Medical Concepts Inc. contributes to advancements in surgical techniques, positioning itself as a pivotal player within the healthcare and medical device industry.